Micro Emerging Active

CGEN stock up 135% faces $44M trim by Kynam Capital

Score
0.3
Velocity
▲ 0.0
Articles
2
Sources
1

Summary

An article belongs to this narrative if it discusses changes in institutional holdings of CG Oncology.

Related Articles

This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight …

Nasdaq · Mar 22, 2026
Mixed

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should …

Nasdaq · Mar 21, 2026
Mixed

Sources

This Biotech Stock Winner Is Up 72%, but a $4 … Nasdaq
This Biotech Stock Up 135% Just Faced a $44 Million … Nasdaq

Timeline

Last Updated Mar 21, 2026